Fifteen years of gene therapy experience allows us at agtc to design and construct all critical gene therapy elements and bring them together to develop successful treatments for patients. For financial reporting, their fiscal year ends on december 31st.
Legal name american gene technologies international inc.
American gene technologies international inc. stock. Agt is pioneering disease solutions to achieve permanent cures for human diseases. Agt's programs are designed to: Genapsys developed a highly accurate direct electronic sequencing technology.
May 2021 individual participant data (ipd) sharing statement:. Biotechnology rockville, maryland 2,092 followers our mission is to leverage the power of gene and cell therapy to reduce human suffering from serious. American gene technologies international inc.
American gene technologies (agt) is a private biotechnology company supported by accredited investors. Security and exchange commission and incorporated in the state of delaware. September 23, 2020 key record dates:
Gene) has agreed to acquire easydna's brand and distribution rights from belhealth for $4 million in cash and stock. Company profile page for american gene technologies international inc including stock price, company news, press releases, executives, board members, and contact information American gene technologies international inc.
Create immunotherapy for hiv disease with gene modified t cells. (agt) is a private biotechnology company pursuing cures and treatments for infectious diseases, cancers and monogenic disorders. Is regulated by the u.s.
(agt), a leading gene and cell therapy company, today announced completion of the pilot runs of its. Gene therapy at its finest genetic therapies are complex, with interdependent components that must work in harmony. American gene technologies international inc.
American gene technologies international inc. Activate innate t cell immunity capable of killing all tumor cells with. American gene technologies (agt) is a genetic medicines company developing a portfolio of therapies that employ the company’s proprietary lentiviral vector (lv) platform to focus on disease in.
American gene technologies international inc. Nct04561258 other study id numbers: May 13, 2021 last verified:
The company develops genetic medicines that meet unmet medical needs in inherited or acquired diseases through the application of viral vector technology. American gene technologies is a gene and cell therapeutics company with a proprietary.